H. İ. Açar And B. Güvenç, "Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience," HEMATOLOGY REPORTS , vol.15, no.3, pp.465-473, 2023
Açar, H. İ. And Güvenç, B. 2023. Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience. HEMATOLOGY REPORTS , vol.15, no.3 , 465-473.
Açar, H. İ., & Güvenç, B., (2023). Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience. HEMATOLOGY REPORTS , vol.15, no.3, 465-473.
Açar, Halil, And BİROL GÜVENÇ. "Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience," HEMATOLOGY REPORTS , vol.15, no.3, 465-473, 2023
Açar, Halil İ. And Güvenç, BİROL. "Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience." HEMATOLOGY REPORTS , vol.15, no.3, pp.465-473, 2023
Açar, H. İ. And Güvenç, B. (2023) . "Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience." HEMATOLOGY REPORTS , vol.15, no.3, pp.465-473.
@article{article, author={Halil İbrahim Açar And author={BİROL GÜVENÇ}, title={Efficacy of Bendamustine, Pomalidomide, and Dexamethasone (BPD) Regimen in Relapsed/Refractory Extramedullary Myeloma: A Retrospective Single-Centre Study, Real-Life Experience}, journal={HEMATOLOGY REPORTS}, year=2023, pages={465-473} }